Weight Loss with Canaglifozin Linked to Improvement in Nonalcoholic Fatty Liver Disease
Clinicians frequently overlook nonalcoholic fatty liver disease in their patients who have Type 2 diabetes. Yet it is estimated that approximately 70% of obese鈥�
Stories and news
-
-
Head-on Approach to a Growing Crisis
Dear colleagues, At University of Florida, the Division of Endocrinology, Diabetes and Metabolism is conducting leading-edge research to learn more about the鈥�
